Posted by Michael Wonder on 10 May 2021
Medicines for colorectal, skin and ovarian cancers approved for NHS Scotland use
10 May 2021 - The Scottish Medicines Consortium accepted a treatment of colorectal cancer in patients with a gene mutation called ‘BRAF V600’.
The SMC announced it has accepted four new medicines for routine use from Monday including Encorafenib (Braftovi), hydrochloride (Ledaga), niraparib (Zejula) and Ravulizumab (Ultomiris).
